UHRF1 promotes androgen receptor-regulated CDC6 transcription and anti-androgen receptor drug resistance in prostate cancer through KDM4C-Mediated chromatin modifications.

MLA

Gao, Yingxue, et al. “UHRF1 Promotes Androgen Receptor-Regulated CDC6 Transcription and Anti-Androgen Receptor Drug Resistance in Prostate Cancer through KDM4C-Mediated Chromatin Modifications.” Cancer Letters, vol. 520, Nov. 2021, pp. 172–83. EBSCOhost, https://doi.org/10.1016/j.canlet.2021.07.012.

APA

Gao, Y., Liu, Y., Liu, Y., Peng, Y., Yuan, B., Fu, Y., Qi, X., Zhu, Q., Cao, T., Zhang, S., Yin, L., & Li, X. (2021). UHRF1 promotes androgen receptor-regulated CDC6 transcription and anti-androgen receptor drug resistance in prostate cancer through KDM4C-Mediated chromatin modifications. Cancer Letters, 520, 172–183. https://doi.org/10.1016/j.canlet.2021.07.012

Chicago

Gao, Yingxue, Yijun Liu, Youhong Liu, Yuchong Peng, Bowen Yuan, Yuxin Fu, Xuli Qi, et al. 2021. “UHRF1 Promotes Androgen Receptor-Regulated CDC6 Transcription and Anti-Androgen Receptor Drug Resistance in Prostate Cancer through KDM4C-Mediated Chromatin Modifications.” Cancer Letters 520 (November): 172–83. doi:10.1016/j.canlet.2021.07.012.